At DTx, we are a group of flexible, innovative thinkers who are determined to solve one of the biggest challenges limiting the development of genetic medicines.
Location: United States, California, San Diego
Employees: 11-50
Total raised: $103M
Founded date: 2017
Investors 5
| Date | Name | Website |
| - | Access Bio... | accessbio-... |
| - | RA Capital... | racap.com |
| - | Tech Coast... | techcoasta... |
| - | SeedFolio | seedfolio.... |
| - | Tachyon Ve... | tachyon.vc |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 17.03.2021 | Series B | $100M | - |
| 14.05.2019 | - | $3M | - |
Mentions in press and media 26
| Date | Title | Description | Source |
| 28.07.2023 | Latest Updates of 7 Viva's Portfolio Companies | HONG KONG, July 28, 2023 /PRNewswire/ -- In the face of ever-changing circumstances, technological i... | en.prnasia... |
| 18.07.2023 | Novartis Acquires DTx Pharma, for Approx. USD1 Billion | Novartis acquired DTx Pharma, a San Diego, CA-based biotechnology company, for approx. $1 Billion. ... | finsmes.co... |
| 18.07.2023 | Viva Biotech's Portfolio Company DTx Pharma Reached the Acqu... | DTx Pharma's Fatty Acid Ligand Conjugated Oligonucleotide (FALCON™) platform facilitates extra-hepat... | en.prnasia... |
| 04.06.2022 | From Stem Cells to Biosensors: 3 Trends To Watch at This Yea... | Some 15-odd years ago, the Alliance for SoCal Innovation put on a workshop for academics looking to ... | dot.la/fir... |
| 07.04.2021 | DTx Pharma to Participate in the 2021 Needham Virtual Health... | SAN DIEGO, April 7, 2021 /PRNewswire/ -- DTx Pharma, Inc. (DTx), a privately-held biotechnology co... | prnewswire... |
| 17.03.2021 | DTx Pharma Raises $100 Million Round | Photo courtesy of DTx Pharma. In May 2020, the biotech expanded its footprint into a new 14,000 squa... | sdbj.com/n... |
| 05.03.2021 | DTx Pharma Closes $100M Series B Financing | DTx Pharma, Inc., a San Diego, CA-based biotechnology company creating novel RNA-based therapeutics ... | finsmes.co... |
| 04.03.2021 | DTx soars to $100 million Series B to advance falcon™Platfor... | We were first introduced to DTx founder and CEO Artie Suckow in June 2017. DTx formed to unlock RNA ... | exsightven... |
| 01.03.2021 | DTx Pharma Completes $100M Series B Financing to Advance its... | SAN DIEGO, March 1, 2021 /PRNewswire/ -- DTx Pharma, Inc. (DTx), a privately-held biotechnology co... | prnewswire... |
| 01.03.2021 | DTx Pharma Finds $100M | San Diego-based DTx Pharma, a biotech startup which is developing RNA-based therapeutics to treat di... | socaltech.... |
Show more